These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36320380)

  • 1. The European structural and investment funds and public investment in the EU countries.
    Staehr K; Urke K
    Empirica (Dordr); 2022; 49(4):1031-1062. PubMed ID: 36320380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luxembourg and Ireland in global financial networks: Analysing the changing structure of European investment funds.
    Wójcik D; Urban M; Dörry S
    Trans Inst Br Geogr; 2022 Jun; 47(2):514-528. PubMed ID: 35910281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the European Structural and Investment Funds in Financing Health System in Lithuania: Experience from 2007 to 2013 funding period and implications for the future.
    Murauskiene L; Karanikolos M
    Health Policy; 2017 Jul; 121(7):727-730. PubMed ID: 28571667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public health research support through the European structural funds in central and eastern Europe and the Mediterranean.
    McCarthy M
    Health Res Policy Syst; 2012 Apr; 10():12. PubMed ID: 22480250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Realization of the EU's Cohesion Policy in Health Care in the Visegrad Group Countries in the Perspective 2014-2020.
    Holecki T; Kowalska-Bobko I; Fraczkiewicz-Wronka A; Wegrzyn M
    Front Public Health; 2020; 8():133. PubMed ID: 32391306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Union Structural Funds as the Source of Financing Health Care Infrastructure Investments in Poland-A Longitudinal Analysis.
    Dubas-Jakóbczyk K; Kozieł A
    Front Public Health; 2022; 10():873433. PubMed ID: 35400058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
    Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
    Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomedical and health research: an analysis of country participation and research fields in the EU's Horizon 2020.
    Gallo F; Seniori Costantini A; Puglisi MT; Barton N
    Eur J Epidemiol; 2021 Dec; 36(12):1209-1217. PubMed ID: 33205246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [European Union funds and clinical toxicology].
    Wiszniewiecka M; Cejrowski D; Sein Anand J
    Przegl Lek; 2015; 72(9):491-2. PubMed ID: 26827576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the EU shirking responsibility for its deforestation footprint in tropical countries? Power, material, and epistemic inequalities in the EU's global environmental governance.
    Kumeh EM; Ramcilovic-Suominen S
    Sustain Sci; 2023; 18(2):599-616. PubMed ID: 36845358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unified autonomous Europe? Public opinion of the EU's foreign and security policy.
    Wang C; Moise AD
    J Eur Public Policy; 2023; 30(8):1679-1698. PubMed ID: 37377447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of subject areas and country participation for all health-related projects in the EU's FP5 and FP6 programmes.
    Galsworthy MJ; Irwin R; Charlesworth K; Ernst K; Hristovski D; Wismar M; McKee M
    Eur J Public Health; 2014 Jun; 24(3):514-20. PubMed ID: 23804079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing health inequalities by using Structural Funds. A question of opportunities.
    Neagu OM; Michelsen K; Watson J; Dowdeswell B; Brand H
    Health Policy; 2017 Mar; 121(3):300-306. PubMed ID: 28104303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Measure to Target Antipoverty Policies in the European Union Regions.
    Annoni P; Weziak-Bialowolska D
    Appl Res Qual Life; 2016; 11(1):181-207. PubMed ID: 26893791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electronic Communication with Public Administration in the Time of COVID-19-Poland's Experience.
    Klich A
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33466944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustainability of Long-term Care: Puzzling Tasks Ahead for Policy-Makers.
    Mosca I; van der Wees PJ; Mot ES; Wammes JJG; Jeurissen PPT
    Int J Health Policy Manag; 2017 Apr; 6(4):195-205. PubMed ID: 28812803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis on funds application of community based organizations involved in HIV/AIDS response and government financial investment in China, 2014].
    Zhang G; Zhu YX; Wang P; Liu P; Li JF; Sha S; Yang WZ; Li H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Mar; 51(3):232-236. PubMed ID: 28260337
    [No Abstract]   [Full Text] [Related]  

  • 19. Increasing European Support for Neglected Infectious Disease Research.
    Olesen OF; Ackermann M
    Comput Struct Biotechnol J; 2017; 15():180-184. PubMed ID: 28179980
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.